WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has stepped down from his position at the Food and Drug Administration (FDA) ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Note that some links may require registration or subscription. FDA vaccine chief Vinay Prasad, MD, MPH, who made the controversial decision to refuse to review Moderna's mRNA flu vaccine, has been ...

Eswar Prasad of Cornell University and author of "The Doom Loop" discusses how political leaders across the world are shifting to a more nationalistic approach in their economic and geopolitical ...

A gay California man has died due to injuries from a November assault that authorities believe was a hate crime. The alleged attacker, 25-year-old Sean Wesley Payton Jr., now faces homicide charges.

A gay California man assaulted in what authorities say was a hate crime on Halloween night has died of his injuries. Now his accused attacker is facing a homicide charge. Sean Wesley Payton Jr., 25, ...

TURNING NOW TO THIS, A TRAGIC UPDATE TO A STORY WE’VE BEEN FOLLOWING SINCE HALLOWEEN. A MAN WHO POLICE SAY WAS THE VICTIM OF A HATE CRIME HAS DIED, AND THE SUSPECT ARRESTED FOR THE ATTACK IS NOW ...

Discover What’s Streaming On: The fifth and final season of Netflix‘s Stranger Things has completely upended our understanding of the Upside Down, revealed Will Byers (Noah Schnapp) as a secret ...

Rohit Prasad is stepping down, while Amazon puts Peter DeSantis in charge of AI models, chips, and quantum computing. Rohit Prasad is stepping down, while Amazon puts Peter DeSantis in charge of AI ...

Rohit Prasad, the executive who has led Amazon’s artificial intelligence initiatives and overseen the creation of its homegrown Nova AI models, is leaving the company at the end of the year. In a memo ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...